Rafael Holdings Inc
For the period ended Jul 31, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Nov 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
| Rafael Holdings, Inc. | |
| By: | /s/ William Conkling |
| William Conkling | |
| Chief Executive Officer |
Date: November 6, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Titles | Date |
|---|---|---|
| /s/ William Conkling | President and Chief Executive Officer (Principal Executive Officer) | November 5, 2024 |
| William Conkling | ||
| /s/ David Polinsky | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | November 5, 2024 |
| David Polinsky | ||
| /s/ Howard S. Jonas | Director, Chairman of the Board and Executive Chairman | November 5, 2024 |
| Howard S. Jonas | ||
| /s/ Susan Y. Bernstein | Director | November 5, 2024 |
| Susan Y. Bernstein | ||
| /s/ Stephen Greenberg | Director | November 5, 2024 |
| Stephen Greenberg | ||
| /s/ Dr. Mark Stein | Director | November 5, 2024 |
| Dr. Mark Stein | ||
| /s/ Dr. Michael J. Weiss | Director | November 5, 2024 |
| Dr. Michael J. Weiss | ||
Index to Consolidated Financial Statements
| Report of Independent Registered Public Accounting Firm (PCAOB ID 596) | F-2 |
|---|---|
| Consolidated Balance Sheets as of July 31, 2024 and 2023 | F-3 |
| Consolidated Statements of Operations and Comprehensive Loss for the years ended July 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Equity for the years ended July 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Cash Flows for the years ended July 31, 2024 and 2023 | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.